| Stuart Steinberg, Dpm | |
|
191 S Buena Vista St Ste 315, Burbank, CA 91505-4556 | |
| (818) 848-5586 | |
| (818) 848-2067 |
| Full Name | Stuart Steinberg, Dpm |
|---|---|
| Type | Facility |
| Speciality | Podiatrist |
| Location | 191 S Buena Vista St Ste 315, Burbank, California |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013926203 | NPI | - | NPPES |
| 000E25860 | Other | CA | BLUE SHIELD IND ID# |
| ZZZ09632Z | Other | CA | BLUE SHIELD GROUP ID# |
| E2586 | Other | CA | STATE LICENSE # |
| 199451800 | Other | CA | US DEPT OF LABOR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | E2586 (California) | Primary |
| 213ES0131X | Podiatrist - Foot Surgery | E2586 (California) | Secondary |
| Provider Name | Joseph Kim Park |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1982886412 PECOS PAC ID: 1355490731 Enrollment ID: I20090728000352 |
News Archive
Ligand Pharmaceuticals Incorporated today announced that its partner GlaxoSmithKline has received a positive opinion for Revolade® (eltrombopag/Promacta®) from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for the oral treatment of thrombocytopenia (reduced platelet count) in adults with the blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP).
Despite many successes, modern medicine is still struggling to find effective treatments for serious pathologies such as cancer and neurodegenerative and inflammatory diseases. For Alzheimer's disease, for example, only 30% of patients respond to therapy whereas for cancers the figure is only 25%.
The American Academy of Pediatrics (AAP) can offer pediatricians from across the country with diverse expertise to discuss the impact of the government shutdown on children. Pediatricians can speak to the on-the-ground impact of the shutdown on federally funded programs such as WIC and Head Start; can contextualize the national position of the AAP to Congress; and can provide local perspectives on why the shutdown is especially harmful to vulnerable children and families.
Medtronic, Inc. (NYSE:MDT), today announced the full U.S. launch of the KYPHON Cement Delivery System (CDS), adding an innovative bone cement delivery option to its extensive KYPHON Balloon Kyphoplasty product portfolio for the treatment of vertebral compression fractures (VCFs).
› Verified 3 days ago
| Provider Name | Tina Shahin |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1912450214 PECOS PAC ID: 0143561647 Enrollment ID: I20190410002185 |
News Archive
Ligand Pharmaceuticals Incorporated today announced that its partner GlaxoSmithKline has received a positive opinion for Revolade® (eltrombopag/Promacta®) from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for the oral treatment of thrombocytopenia (reduced platelet count) in adults with the blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP).
Despite many successes, modern medicine is still struggling to find effective treatments for serious pathologies such as cancer and neurodegenerative and inflammatory diseases. For Alzheimer's disease, for example, only 30% of patients respond to therapy whereas for cancers the figure is only 25%.
The American Academy of Pediatrics (AAP) can offer pediatricians from across the country with diverse expertise to discuss the impact of the government shutdown on children. Pediatricians can speak to the on-the-ground impact of the shutdown on federally funded programs such as WIC and Head Start; can contextualize the national position of the AAP to Congress; and can provide local perspectives on why the shutdown is especially harmful to vulnerable children and families.
Medtronic, Inc. (NYSE:MDT), today announced the full U.S. launch of the KYPHON Cement Delivery System (CDS), adding an innovative bone cement delivery option to its extensive KYPHON Balloon Kyphoplasty product portfolio for the treatment of vertebral compression fractures (VCFs).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stuart Steinberg, Dpm 191 S Buena Vista St Ste 315, Burbank, CA 91505-4556 Ph: (818) 848-5586 | Stuart Steinberg, Dpm 191 S Buena Vista St Ste 315, Burbank, CA 91505-4556 Ph: (818) 848-5586 |
News Archive
Ligand Pharmaceuticals Incorporated today announced that its partner GlaxoSmithKline has received a positive opinion for Revolade® (eltrombopag/Promacta®) from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for the oral treatment of thrombocytopenia (reduced platelet count) in adults with the blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP).
Despite many successes, modern medicine is still struggling to find effective treatments for serious pathologies such as cancer and neurodegenerative and inflammatory diseases. For Alzheimer's disease, for example, only 30% of patients respond to therapy whereas for cancers the figure is only 25%.
The American Academy of Pediatrics (AAP) can offer pediatricians from across the country with diverse expertise to discuss the impact of the government shutdown on children. Pediatricians can speak to the on-the-ground impact of the shutdown on federally funded programs such as WIC and Head Start; can contextualize the national position of the AAP to Congress; and can provide local perspectives on why the shutdown is especially harmful to vulnerable children and families.
Medtronic, Inc. (NYSE:MDT), today announced the full U.S. launch of the KYPHON Cement Delivery System (CDS), adding an innovative bone cement delivery option to its extensive KYPHON Balloon Kyphoplasty product portfolio for the treatment of vertebral compression fractures (VCFs).
› Verified 3 days ago
Toes Are Us Inc Podiatrist Medicare: Medicare Enrolled Practice Location: 207 W Alameda Ave Ste 103, Burbank, CA 91502 Phone: 747-241-8344 | |
Dr. John Donald Halebian, DPM CWS Podiatrist Medicare: Medicare Enrolled Practice Location: 531 N Beachwood Dr, Burbank, CA 91506 Phone: 818-508-0177 Fax: 818-566-1829 | |
John W Wall, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1411 W Olive Ave, Suite C, Burbank, CA 91506 Phone: 818-846-4122 Fax: 818-848-8634 | |
American Podiatry Corporation Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3906 W Burbank Blvd, Burbank, CA 91505 Phone: 818-238-9892 | |
Burbank Foot Doctors Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3906 W Burbank Blvd, Burbank, CA 91505 Phone: 818-238-9892 Fax: 818-238-9893 | |
Dr. Oliver Wang, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 241 W Olive Ave, Burbank, CA 91502 Phone: 818-848-5583 Fax: 818-848-1872 |